ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
32,867,000
32,753,000
28,216,000
25,638,000
Cost of Revenue
7,455,000
7,718,000
7,040,000
5,833,000
Gross Profit
25,412,000
25,035,000
21,176,000
19,805,000
Operating Expenses
Research Development
11,360,000
10,329,000
4,982,000
4,366,000
Selling General and Administrative
6,920,000
7,399,000
6,275,000
5,855,000
Total Operating Expenses
18,280,000
18,228,000
11,257,000
10,221,000
Operating Income or Loss
7,132,000
6,807,000
9,919,000
9,584,000
Interest Expense
1,605,000
1,348,000
1,150,000
1,047,000
Total Other Income/Expenses Net
-2,780,000
-466,000
-1,188,000
-735,000
Income Before Tax
2,979,000
5,197,000
7,727,000
7,884,000
Income Tax Expense
-276,000
-490,000
2,418,000
1,931,000
Income from Continuing Operations
3,255,000
5,687,000
5,309,000
5,953,000
Net Income
3,255,000
5,687,000
5,309,000
5,953,000
Net Income available to common shareholders
3,232,000
5,687,000
5,309,000
5,953,000
Reported EPS
Basic
-
3.85
3.33
3.74
Diluted
-
3.66
3.30
3.63
Weighted average shares outstanding
Basic
-
1,478,824
1,592,131
1,592,513
Diluted
-
1,546,000
1,603,000
1,631,000
EBITDA
-
6,807,000
9,919,000
9,584,000